Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Christian Huisman, Monique GP van der Wijst, Fahimeh Falahi, Juul Overkamp, Gellért Karsten, Martijn M Terpstra, Klaas Kok, Ate GJ van der Zee, Ed Schuuring, G Bea A Wisman & Marianne G Rots. (2015) Prolonged re-expression of the hypermethylated gene EPB41L3 using artificial transcription factors and epigenetic drugs. Epigenetics 10:5, pages 384-396.
Read now
Read now
Articles from other publishers (44)
Xinyu Liu, Wenjing Li, Licheng Xu, Xiaoxue Chen, Rui Zhao, Yan Guo, Jingchun Ge, Zhenming Yang, Liang Li, Jiarui Zhang, Jing Cao, Yue Shao, Xinyue Guo, Linli Tian & Ming Liu. (2023) Chidamide, a novel histone deacetylase inhibitor, inhibits laryngeal cancer progression in vitro and in vivo. The International Journal of Biochemistry & Cell Biology 158, pages 106398.
Crossref
Crossref
María Ovejero-Sánchez, Gloria Asensio-Juárez, Myriam González, Pilar Puebla, Miguel Vicente-Manzanares, Rafael Pélaez, Rogelio González-Sarmiento & Ana Belén Herrero. (2022) Panobinostat Synergistically Enhances the Cytotoxicity of Microtubule Destabilizing Drugs in Ovarian Cancer Cells. International Journal of Molecular Sciences 23:21, pages 13019.
Crossref
Crossref
Runjhun Mathur, Niraj Kumar Jha, Gaurav Saini, Saurabh Kumar Jha, Sheo Prasad Shukla, Zita Filipejová, Kavindra Kumar Kesari, Danish Iqbal, Parma Nand, Vijay Jagdish Upadhye, Abhimanyu Kumar Jha, Shubhadeep Roychoudhury & Petr Slama. (2022) Epigenetic factors in breast cancer therapy. Frontiers in Genetics 13.
Crossref
Crossref
Zhi Hung Yap, Wei Yang Kong, Abdur Rahmaan Azeez, Chee-Mun Fang & Siew Ching Ngai. (2022) Anti-Cancer Effects of Epigenetics Drugs Scriptaid and Zebularine in Human Breast Adenocarcinoma Cells. Anti-Cancer Agents in Medicinal Chemistry 22:8, pages 1582-1591.
Crossref
Crossref
Nuraqila Mohd Murshid, Faridah Aminullah Lubis & Suzana Makpol. (2020) Epigenetic Changes and Its Intervention in Age-Related Neurodegenerative Diseases. Cellular and Molecular Neurobiology 42:3, pages 577-595.
Crossref
Crossref
JunMing Sun, QingYou Liu, LingYan Lv, RuYu Sun, Zhi Peng Li, Ben Huang, KuiQing Cui & DeShun Shi. (2021) HDAC6 Is Involved in the Histone Deacetylation of In Vitro Maturation Oocytes and the Reprogramming of Nuclear Transplantation in Pig. Reproductive Sciences 28:9, pages 2630-2640.
Crossref
Crossref
María Ovejero-Sánchez, Rogelio González-Sarmiento & Ana Belén Herrero. (2021) Synergistic effect of Chloroquine and Panobinostat in ovarian cancer through induction of DNA damage and inhibition of DNA repair. Neoplasia 23:5, pages 515-528.
Crossref
Crossref
Samir Zakhari & Jan Hoek. (2018) Epidemiology of Moderate Alcohol Consumption and Breast Cancer: Association or Causation?. Cancers 10:10, pages 349.
Crossref
Crossref
Jovana Klajic & Vessela Kristensen. 2018. Epigenetic Mechanisms in Cancer. Epigenetic Mechanisms in Cancer
141
168
.
B. Müller, C. Heinrich, W. Jabs, S. Kaspar-Schönefeld, A. Schmidt, N. Rodrigues de Carvalho, S.P. Albaum, C. Baessmann, T. Noll & R Hoffrogge. (2017) Label-free protein quantification of sodium butyrate treated CHO cells by ESI-UHR-TOF-MS. Journal of Biotechnology 257, pages 87-98.
Crossref
Crossref
Masahiro Kizaki & Takayuki Tabayashi. (2016) The Role of Intracellular Signaling Pathways in the Pathogenesis of Multiple Myeloma and Novel Therapeutic Approaches. Journal of Clinical and Experimental Hematopathology 56:1, pages 20-27.
Crossref
Crossref
Marc Wingens, Jochem Gätgens, Anica Schmidt, Stefan P. Albaum, Heino Büntemeyer, Thomas Noll & Raimund Hoffrogge. (2015) 2D-DIGE screening of high-productive CHO cells under glucose limitation—Basic changes in the proteome equipment and hints for epigenetic effects. Journal of Biotechnology 201, pages 86-97.
Crossref
Crossref
J‐A Shin, G Han, S‐K Park, K Lee, H‐J Kim, S‐D Cho & HM Kim. (2013)
The
in vitro
apoptotic effects of A248 and A1659, newly synthetic histone deacetylase inhibitors in oral cancer cells
. Oral Diseases 20:5, pages 482-489.
Crossref
Crossref
Michal Bitman, Radim Vrzal, Zdenek Dvorak & Petr Pavek. (2014) Valproate activates ERK signaling pathway in primary human hepatocytes. Biomedical Papers 158:1, pages 039-043.
Crossref
Crossref
Zheng-Yuan Su, Chengyue Zhang, Jong Hun Lee, Limin Shu, Tien-Yuan Wu, Tin Oo Khor, Allan H. Conney, Yao-Ping Lu & Ah-Ng Tony Kong. (2014) Requirement and Epigenetics Reprogramming of Nrf2 in Suppression of Tumor Promoter TPA-Induced Mouse Skin Cell Transformation by Sulforaphane. Cancer Prevention Research 7:3, pages 319-329.
Crossref
Crossref
T.V. Shiva Shankar & L. Willems. (2014) Epigenetic modulators mitigate angiogenesis through a complex transcriptomic network. Vascular Pharmacology 60:2, pages 57-66.
Crossref
Crossref
Mario Solís-Paredes, Pilar Eguía-Aguilar, Fernando Chico-Ponce de León, Stanislaw Sadowinski-Pine, Mario Pérezpeña-Diazconti & Francisco Arenas-Huertero. (2013) Epigenetic modifications in cell lines of human astrocytoma differentially regulate expression of apoptotic genes. Child's Nervous System 30:1, pages 123-129.
Crossref
Crossref
Natalie Turner, Erica Moretti, Olimpia Siclari, Ilenia Migliaccio, Libero Santarpia, Maurizio D’Incalci, Stefano Piccolo, Andrea Veronesi, Alberto Zambelli, Gianni Del Sal & Angelo Di Leo. (2013) Targeting triple negative breast cancer: Is p53 the answer?. Cancer Treatment Reviews 39:5, pages 541-550.
Crossref
Crossref
M. Razafsha, H. Behforuzi, H. Harati, R.AL. Wafai, A. Khaku, S. Mondello, M.S. Gold & F.H. Kobeissy. (2013) An updated overview of animal models in neuropsychiatry. Neuroscience 240, pages 204-218.
Crossref
Crossref
Chengyue Zhang, Zheng-Yuan Su, Tin Oo Khor, Limin Shu & Ah-Ng Tony Kong. (2013) Sulforaphane enhances Nrf2 expression in prostate cancer TRAMP C1 cells through epigenetic regulation. Biochemical Pharmacology 85:9, pages 1398-1404.
Crossref
Crossref
Nathan G. Dolloff & Giampaolo Talamo. 2013. Impact of Genetic Targets on Cancer Therapy. Impact of Genetic Targets on Cancer Therapy
197
221
.
Elke De Bruyne, Ken Maes, Sarah Deleu, Els Van Valckenborgh, Eline Menu, Isabelle Vande Broek, Joanna Fraczek, Leo van Grunsven, Vera Rogiers, Helena Jernberg-Wiklund & Karin Vanderkerken. 2013. Advances in Biology and Therapy of Multiple Myeloma. Advances in Biology and Therapy of Multiple Myeloma
255
282
.
Jinah Park, Eunju Park, Sae-Won Han, Seock-Ah Im, Tae-You Kim, Woo-Ho Kim, Do-Youn Oh & Yung-Jue Bang. (2011) Down-regulation of P-cadherin with PF-03732010 inhibits cell migration and tumor growth in gastric cancer. Investigational New Drugs 30:4, pages 1404-1412.
Crossref
Crossref
Sebastian Bultmann, Robert Morbitzer, Christine S. Schmidt, Katharina Thanisch, Fabio Spada, Janett Elsaesser, Thomas Lahaye & Heinrich Leonhardt. (2012) Targeted transcriptional activation of silent oct4 pluripotency gene by combining designer TALEs and inhibition of epigenetic modifiers. Nucleic Acids Research 40:12, pages 5368-5377.
Crossref
Crossref
Philippe Moreau. (2012) The Future of Therapy for Relapsed/Refractory Multiple Myeloma: Emerging Agents and Novel Treatment Strategies. Seminars in Hematology 49, pages S33-S46.
Crossref
Crossref
Jorge Antonio Bermúdez-Lugo, Oscar Perez-Gonzalez, Martha Cecilia Rosales-Hernández, Ian Ilizaliturri-Flores, José Trujillo-Ferrara & Jose Correa-Basurto. (2011) Exploration of the valproic acid binding site on histone deacetylase 8 using docking and molecular dynamic simulations. Journal of Molecular Modeling 18:6, pages 2301-2310.
Crossref
Crossref
Shyh-Kuan Tai, Hsin-Chuan Chang, Keng-Li Lan, Chun-Ting Lee, Chih-Ya Yang, Nien-Jung Chen, Teh-Ying Chou, Der-Cherng Tarng & Shie-Liang Hsieh. (2012) Decoy Receptor 3 Enhances Tumor Progression via Induction of Tumor-Associated Macrophages. The Journal of Immunology 188:5, pages 2464-2471.
Crossref
Crossref
Lawrence S. Baszkowsky, Jeffrey G. Supko,Bruce A. Chabner. 2012. Clinical Radiation Oncology. Clinical Radiation Oncology
165
179
.
Paola Bendinelli, Paola Maroni, Emanuela Matteucci & Maria Alfonsina Desiderio. (2011) Comparative role of acetylation along c-SRC/ETS1 signaling pathway in bone metastatic and invasive mammary cell phenotypes. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1813:10, pages 1767-1776.
Crossref
Crossref
Giorgia Urbinati, Véronique Marsaud, Valérie Nicolas, Juliette Vergnaud-Gauduchon & Jack-Michel Renoir. (2011) Liposomal trichostatin A: therapeutic potential in hormone-dependent and -independent breast cancer xenograft models. Hormone Molecular Biology and Clinical Investigation 6:2.
Crossref
Crossref
Meletios A. Dimopoulos, Jesus F. San-Miguel & Kenneth C. Anderson. (2011) Emerging therapies for the treatment of relapsed or refractory multiple myeloma. European Journal of Haematology 86:1, pages 1-15.
Crossref
Crossref
Giorgia Urbinati, Véronique Marsaud, Vincent Plassat, Elias Fattal, Sylviane Lesieur & Jack-Michel Renoir. (2010) Liposomes loaded with histone deacetylase inhibitors for breast cancer therapy. International Journal of Pharmaceutics 397:1-2, pages 184-193.
Crossref
Crossref
Leonel Maldonado & Mohammad Obaidul Hoque. (2010) Epigenomics and ovarian carcinoma. Biomarkers in Medicine 4:4, pages 543-570.
Crossref
Crossref
Jovana Jovanovic, Jo Anders Rønneberg, Jörg Tost & Vessela Kristensen. (2010) The epigenetics of breast cancer. Molecular Oncology 4:3, pages 242-254.
Crossref
Crossref
Pritika Narayan & Mike Dragunow. (2010) Pharmacology of epigenetics in brain disorders. British Journal of Pharmacology 159:2, pages 285-303.
Crossref
Crossref
Jonas Steinmann, Skarphéđinn Halldórsson, Birgitta Agerberth & Gudmundur H. Gudmundsson. (2009) Phenylbutyrate Induces Antimicrobial Peptide Expression. Antimicrobial Agents and Chemotherapy 53:12, pages 5127-5133.
Crossref
Crossref
S. Dean RiderJr.Jr. & Guan Zhu. (2009) An apicomplexan ankyrin-repeat histone deacetylase with relatives in photosynthetic eukaryotes. International Journal for Parasitology 39:7, pages 747-754.
Crossref
Crossref
M. W. Lawless, S. Norris, K. J. O’Byrne & S. G. Gray. (2009) Targeting histone deacetylases for the treatment of disease. Journal of Cellular and Molecular Medicine 13:5, pages 826-852.
Crossref
Crossref
Anne S. TsaoIgnacio WistubaJack A. RothHedy Lee Kindler. (2009) Malignant Pleural Mesothelioma. Journal of Clinical Oncology 27:12, pages 2081-2090.
Crossref
Crossref
Grégory Eot-Houllier, Géraldine Fulcrand, Laura Magnaghi-Jaulin & Christian Jaulin. (2009) Histone deacetylase inhibitors and genomic instability. Cancer Letters 274:2, pages 169-176.
Crossref
Crossref
Pang-Kuo LoSaraswati Sukumar. (2008) Epigenomics and breast cancer. Pharmacogenomics 9:12, pages 1879-1902.
Crossref
Crossref
Leonard Blackwell, Jacqueline Norris, Carla M. Suto & William P. Janzen. (2008) The use of diversity profiling to characterize chemical modulators of the histone deacetylases. Life Sciences 82:21-22, pages 1050-1058.
Crossref
Crossref
Muhummadh Khan & Kaiser Jamil. (2008) Genomic Distribution, Expression and Pathways of Cancer Metasignature Genes Through Knowledge Based Data Mining. International Journal of Cancer Research 4:4, pages 137-145.
Crossref
Crossref
Ju-Hee Lee, Jung-Hyun Park, Yeonjoo Jung, Jee-Hyun Kim, Hyun-Soon Jong, Tae-You Kim & Yung-Jue Bang. (2006) Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells. Molecular Cancer Therapeutics 5:12, pages 3085-3095.
Crossref
Crossref